Susquehanna International Group, LLP Xeris Biopharma Holdings, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 79,915 shares of XERS stock, worth $269,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,915
Previous 32,246
147.83%
Holding current value
$269,313
Previous $72,000
215.28%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding XERS
# of Institutions
142Shares Held
59.9MCall Options Held
148KPut Options Held
45.7K-
Black Rock Inc. New York, NY10.3MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$26.2 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.2 Million62.59% of portfolio
-
Center Book Partners LP Greenwich, CT3.48MShares$11.7 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA3.33MShares$11.2 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $458M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...